相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
R805
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
51803-78-2
- 规格:
10 mM * 1 mL/100 mg/500 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥550.0 |
|---|---|---|---|
| 规格: | 100 mg | 产品价格: | ¥500.0 |
| 规格: | 500 mg | 产品价格: | ¥900.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Nimesulide
CAS No. : 51803-78-2
MCE 国际站:Nimesulide
产品活性:Nimesulide 是一种有选择性的 COX-2 抑制剂,对其抑制具有时间依赖性,IC50 值为 70 nM-70 μM,但对 COX-1 的作用弱,IC50 值 >100 μM;Nimesulide 具有抗炎、止痛、解热的作用。
作用靶点:COX
In Vitro: Nimesulide is a selective COX-2 inhibitor, with IC50s of 70 nM-70 μM in a time-dependent manner, but it shows weak effect on COX-1 (IC50 >100 μM). Nimesulide (10 µM) effectively decreases VEGF in endometrium cancer cells, and shows no effect on that in normal cells. Nimesulide (10 and 50 µM) dramatically decreases MCP-1 levels in normal cell, and such an effect is also observed with 10 µM in cancer cells. In addition, Nimesulide (50 µM) potently affects IL-8 level in normal cells, but causes no changes in cancer cells.
In Vivo: Nimesulide (3 and 10 mg/kg, i.p.) effectively blocks fever induced by i.p. injection of LPS in rats. Nimesulide (3 mg/kg, i.p.) potently reduces fever response induced by IL-1β, IL-6 or TNF-α, but does not prevent the initial rise in the febrile response induced by arachidonic acid. Nimesulide also significantly reduces PGE2 levels and PGF2α levels in the cerebrospinal fluid of the LPS-stimulated animals, and inhibits the increase in plasma TNF-α by 97%.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Pyroptosis Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Pancreatic Cancer Compound Library | Rare Diseases Drug Library | Anti-Colorectal Cancer Compound Library | Antidepressant Compound Library | EMA-Approved Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Anti-Prostate Cancer Compound Library | Non-steroidal Anti-Inflammatory Compound Library | Withdrawn Drug Compound Library | Off-patent Drug Library | Mitochondrial Toxicity Compound Library | Highly Selective Inhibitors Library | Acetaminophen | Indomethacin | Celecoxib | EIPA | Aspirin | Oxidopamine hydrobromide | Deferiprone | Diclofenac | Gallic acid | Ibuprofen | Catechin | 20(S)-Ginsenoside Rg3 | Cucurbitacin B | Carprofen | Meloxicam | (-)-Epicatechin | NS-398 | Naproxen | Xanthohumol | Flufenamic acid | Salicylic acid | Phenacetin | Ketoprofen | SC-560 | Rebamipide | Ginsenoside Rd
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验耐受。常用于治疗风湿及类风湿性关节炎。 吡罗昔康(炎痛喜康): 为强效、长效解热镇痛抗炎药。每日服药一次。剂量过大或长期服用可致消化道溃疡、出血。 美洛昔康( meloxicam )、尼美舒利( nimesulide ): 选择性抑制 COX-2 ,抗炎作用强而副作用较小,用于治疗各类关节炎及组织炎症。长期应用,胃粘膜损伤及胃肠出血发生率低。 附 抗痛风药 别嘌醇能抑制尿酸
技术资料暂无技术资料 索取技术资料

















